http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210103179-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36e08ba544b18fad9f5453b088bd32ed |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2871 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-285 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-324 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54346 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5768 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5767 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5306 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-553 |
| filingDate | 2020-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccd53a676ed5375ee9fb1710829dc4d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f35b4715e3d7d024da2948edab0d403a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_499b743b6cceef38d141af0fb550f7f4 |
| publicationDate | 2021-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20210103179-A |
| titleOfInvention | 3-dimensional immunodiagnostics based on detection signal control |
| abstract | The present invention realizes self-amplification of detection signals by simultaneously linking immunodiagnosis using a protein nanoparticle-based three-dimensional detection probe and gold particle formation by gold ion reduction in liquid conditions, and at the same time, controls the viscosity control factor of liquid phase. A kit for detecting disease-specific markers, which detects disease-specific markers with an accurate immunodiagnostic method that can reduce the generation of false-positive signals by utilizing metal ions that control the detection signal generation time and do not cause interference with the detection signal The present invention relates to a method for detecting a disease-specific marker used, and more specifically, by controlling the content of a viscosity control factor in a diagnostic solution, it is possible to derive consistent diagnostic results without being affected by differences in the viscosity of samples according to individual differences, as well as In addition to gold ions, metal ions that do not generate optical signals when reduced to metal particles are additionally utilized to solve the problem of false positive noise while dramatically reducing the amount of detection probes (protein nanoparticle-based three-dimensional antibody probes) It relates to a kit for detecting a disease-specific marker, which can significantly reduce manufacturing costs, characterized by high accuracy and economy, and a method for detecting a disease-specific marker using the same. |
| priorityDate | 2020-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 785.